Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Life Sciences research
Advanced Oncotherapy
Life Sciences
Commercialising a breakthrough technology
By
Dr Gregoire Pave
13 May 2019
Shield Therapeutics Plc
Life Sciences
All in the execution
By
Dr Dorothea Hill
13 May 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Advanced Oncotherapy
Life Sciences
Preparing for commercialisation
By
Dr Martin Hall
16 Apr 2019
ValiRx
Life Sciences
VAL401 is going forward
By
Dr Martin Hall
15 Apr 2019
Tissue Regenix
Life Sciences
Expanded GPO coverage secured
By
Dr Martin Hall
10 Apr 2019
Life Sciences
Global Pharmaceuticals: 2018 industry statistics
By
Dr Martin Hall
09 Apr 2019
genedrive Plc
Life Sciences
First commercial sales in new focus area: bio-threats
By
Dr Dorothea Hill
08 Apr 2019
Oxford BioMedica
Life Sciences
Deal-making drives first annual profit
By
Dr Dorothea Hill
02 Apr 2019
Allergy Therapeutics plc
Life Sciences
Take an objective view
By
Dr Dorothea Hill
18 Mar 2019
Allergy Therapeutics plc
Life Sciences
Strong operating performance driving market share
By
Dr Dorothea Hill
06 Mar 2019
Collagen Solutions Plc
Life Sciences
Exciting growth
By
Dr Martin Hall
22 Feb 2019
Prev
1
...
4
5
6
7
8
...
17
Next
